Medicine Status
Lubiprostone 0.024 mg Oral Capsule (also know as Amitiza)
Pill Identifier
Medicine Status
About Medicine Status
Copyright © 2020 and Spring Launch Media LLC. All Rights Reserved.

All content on this website ("the Site") is the property of Spring Launch Media LLC. The collection and assembly of content on this Site are the exclusive property of Spring Launch Media LLC and are protected by copyright and other intellectual property laws. does not provide medical advice, diagnosis, or treatment, and urges you to consult with a qualified medical provider for diagnosis, treatment, and for answers to your medical questions. does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information disclosed. does not assume any responsibility for any aspect of medical care administered based on the contents provided on this Site. The contents of, such as text, images, graphics, or other material are solely for informational purposes. does not recommend or endorse any specific provider, opinions, procedures, or other information on the Site. Rely on any information provided by or displayed on this Site solely at your own risk. Consult a healthcare professional before taking any drug, choosing or changing any course of treatment.

Lubiprostone 0.024 mg Oral Capsule (also know as Amitiza)

Pill Finder Wizard
Overview Lubiprostone 0.024 mg Oral Capsule (also know as Amitiza) is a oval shaped, orange, gelatin coated capsule that is approximately 9 mm in size. It has one score and can be broken into two pieces.

It is imprinted with "SPI" and is supplied by Takeda Pharmaceuticals America, Inc.
Drug Name Amitiza
Dosage Form Gelatin Coated Capsule
Imprint(s) SPI
Pill Size 9 mm
DEA Schedule (Potential for Drug Abuse)
Pill Image
Drug Ingredients
Active Ingredient(s) Lubiprostone
Inactive Ingredient(s) Medium-Chain Triglycerides, Gelatin, Unspecified, Sorbitol, FD&C Red No. 40, D&C Yellow No. 10, Water
Drug Codes
RxNorm Concept Unique Identifier 617,768
National Drug Code 647640240
Marketing Category NDA
Supplier Takeda Pharmaceuticals America, Inc.
References The data for Lubiprostone 0.024 mg Oral Capsule (also know as Amitiza) was updated by the U.S National Library of Medicine on January 18, 2018.

  • U.S. National Library of Medicine. Accessed June 8, 2019.
  • Drug Scheduling. United States Drug Enforcement Administration. Accessed June 8, 2019.
  • Structured Product Labeling Resources. U.S. Food & Drug Administration. March 27, 2018. Accessed June 8, 2019.
  • HL7 Reference Information Model. HL7 Interational. Accessed June 8, 2019.